BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 2021
View Archived Issues
Nippon Shinyaku patents muscarinic acetylcholine M3 receptor positive allosteric modulators
Read More
New mucolipin-1 activators identified at Libra Therapeutics
Read More
Suzhou Zelgen Biosciences divulges Toll-like receptor 7/8 agonists
Read More
New PDE6C and PDE5A inhibitors discovered at ILDONG Pharmaceutical
Read More
Yuhan Corp. and Green Cross Corp. present ceramide glucosyltransferase inhibitors
Read More
GS-3583 well tolerated, expands dendritic cells in healthy subjects
Read More
First-in-human study shows anti-ICOS KY-1044 well tolerated alone and with atezolizumab
Read More
Aivita presents phase II data for its personalized GBM vaccine candidate, AV-GBM-1
Read More
Phase Ib data indicate ST-617 can reduce severity of OM in patients receiving chemoradiation
Read More
Promising interim phase I and II data for BION-1301 in patients with IgA nephropathy
Read More
Early phase II results presented for ponatinib plus blinatumomab combination in Ph+ ALL patients
Read More
Stress sensor DJ-1 can heighten or dampen inflammation
Read More
DZD-9008 shows antitumor activity in NSCLC patients with EGFR exon20 insertion mutations
Read More
FDA approves IND for first-in-human study of CPI-300 in advanced tumors
Read More
Icosavax begins dosing in phase I/II trial of IVX-411 for COVID-19
Read More
Arena begins phase II study of temanogrel for coronary microvascular obstruction
Read More
PDS-0101, M-9241 and bintrafusp alfa combination in advanced HPV16-positive malignancies
Read More
Aclaris reports topline phase IIa data on ATI-1777 in moderate to severe atopic dermatitis
Read More
Cardiff Oncology initiates phase II trial of onvansertib for metastatic pancreatic cancer
Read More
A new selective, reversible BTK inhibitor bearing an imidazo[4,5-b]pyridine scaffold
Read More
Intracellular nanobody delivery for the treatment of intracellular Ehrlichia chaffeensis infection
Read More